Note to Publisher: Pricing information verified via screenshots from official checkout pages dated January 2026
A substudy examining participants with metabolic-associated steatotic liver disease produced results that no pharmacological intervention had previously achieved
Long-acting preparations include lixisenatide (LIXI) and LIR, which are injected once a day
Vilsbll T, Krarup T, Sonne J, Madsbad S, Vlund A, Juul AG, et al
This FDA-approved medication aids in reducing hunger, slowing down digestion, and assisting individuals in maintaining a healthy diet, which results in a gradual and safe reduction of weight
People taking GLP-1 medications who engage in regular exercise had significantly less bone loss than those who do not exercise